These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34034133)

  • 1. Design, synthesis, and biological evaluation of 3-(1-benzotriazole)-nor-β-lapachones as NQO1-directed antitumor agents.
    Wu LQ; Ma X; Liu ZP
    Bioorg Chem; 2021 Aug; 113():104995. PubMed ID: 34034133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of 4-substituted-3,4-dihydrobenzo[h]quinoline-2,5,6(1H)-triones as NQO1-directed antitumor agents.
    Wu LQ; Ma X; Zhang C; Liu ZP
    Eur J Med Chem; 2020 Jul; 198():112396. PubMed ID: 32464425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological activity of 1,4-quinone moiety attached to betulin derivatives as potent DT-diaphorase substrate.
    Kadela-Tomanek M; Jastrzębska M; Marciniec K; Chrobak E; Bębenek E; Latocha M; Kuśmierz D; Boryczka S
    Bioorg Chem; 2021 Jan; 106():104478. PubMed ID: 33272711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1).
    Bian J; Deng B; Xu L; Xu X; Wang N; Hu T; Yao Z; Du J; Yang L; Lei Y; Li X; Sun H; Zhang X; You Q
    Eur J Med Chem; 2014 Jul; 82():56-67. PubMed ID: 24874653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities.
    Ling Y; Yang QX; Teng YN; Chen S; Gao WJ; Guo J; Hsu PL; Liu Y; Morris-Natschke SL; Hung CC; Lee KH
    Eur J Med Chem; 2018 Jun; 154():199-209. PubMed ID: 29803003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel isothiazoloquinoline quinone analogues.
    Chen L; Xie YZ; Luo ZY; Liu LJ; Zou ZZ; Liu HD; Kong FR; Hao Y; Gao JL; Wang LL; Ma DY; Liu SY
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127286. PubMed ID: 32631508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation.
    Xu S; Yao H; Pei L; Hu M; Li D; Qiu Y; Wang G; Wu L; Yao H; Zhu Z; Xu J
    Eur J Med Chem; 2017 May; 132():310-321. PubMed ID: 28395199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel benzofuran derivatives as potent LSD1 inhibitors.
    Zhang X; Huang H; Zhang Z; Yan J; Wu T; Yin W; Sun Y; Wang X; Gu Y; Zhao D; Cheng M
    Eur J Med Chem; 2021 Aug; 220():113501. PubMed ID: 33945992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of quinolinedione-linked sulfonylpiperazine derivatives as NQO1-directed antitumor agents.
    Guo K; Li J; Jia Y; Yang X; Yan X; Wu L
    Bioorg Chem; 2023 Mar; 132():106385. PubMed ID: 36696730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of β-lapachone-monastrol hybrids as potential anticancer agents.
    Wu L; Ma X; Yang X; Zhang C
    Eur J Med Chem; 2020 Oct; 203():112594. PubMed ID: 32682198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bifunctional Naphtho[2,3-
    Zuo Z; Liu X; Qian X; Zeng T; Sang N; Liu H; Zhou Y; Tao L; Zhou X; Su N; Yu Y; Chen Q; Luo Y; Zhao Y
    J Med Chem; 2020 Jul; 63(14):7633-7652. PubMed ID: 32496056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triazoloacridin-6-ones as novel inhibitors of the quinone oxidoreductases NQO1 and NQO2.
    Nolan KA; Humphries MP; Barnes J; Doncaster JR; Caraher MC; Tirelli N; Bryce RA; Whitehead RC; Stratford IJ
    Bioorg Med Chem; 2010 Jan; 18(2):696-706. PubMed ID: 20036559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of 1-(benzofuran-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazole derivatives as tubulin polymerization inhibitors.
    Qi ZY; Hao SY; Tian HZ; Bian HL; Hui L; Chen SW
    Bioorg Chem; 2020 Jan; 94():103392. PubMed ID: 31669093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases.
    Elzahhar PA; Abd El Wahab SM; Elagawany M; Daabees H; Belal ASF; El-Yazbi AF; Eid AH; Alaaeddine R; Hegazy RR; Allam RM; Helmy MW; Bahaa Elgendy ; Angeli A; El-Hawash SA; Supuran CT
    Eur J Med Chem; 2020 Aug; 200():112439. PubMed ID: 32485532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel naphtho[2,1-d]oxazole-4,5-diones as NQO1 substrates with improved aqueous solubility: Design, synthesis, and in vivo antitumor evaluation.
    Li X; Bian J; Wang N; Qian X; Gu J; Mu T; Fan J; Yang X; Li S; Yang T; Sun H; You Q; Zhang X
    Bioorg Med Chem; 2016 Mar; 24(5):1006-13. PubMed ID: 26803578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational designed highly sensitive NQO1-activated near-infrared fluorescent probe combined with NQO1 substrates in vivo: An innovative strategy for NQO1-overexpressing cancer theranostics.
    Gong Q; Yang F; Hu J; Li T; Wang P; Li X; Zhang X
    Eur J Med Chem; 2021 Nov; 224():113707. PubMed ID: 34303080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of (±)-dunnione and its ortho-quinone analogues as substrates for NAD(P)H:quinone oxidoreductase 1 (NQO1).
    Bian J; Xu L; Deng B; Qian X; Fan J; Yang X; Liu F; Xu X; Guo X; Li X; Sun H; You Q; Zhang X
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1244-8. PubMed ID: 25677663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of cation-π interactions in enzyme-substrate binding: Design, synthesis, biological evaluation, and molecular dynamics insights of novel hydrophilic substrates for NQO1.
    Gong Q; Yu Q; Wang N; Hu J; Wang P; Yang F; Li T; You Q; Li X; Zhang X
    Eur J Med Chem; 2021 Oct; 221():113515. PubMed ID: 33984806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells.
    Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA
    Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic studies of cancer cell mitochondria- and NQO1-mediated redox activation of beta-lapachone, a potentially novel anticancer agent.
    Li JZ; Ke Y; Misra HP; Trush MA; Li YR; Zhu H; Jia Z
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):285-93. PubMed ID: 25448047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.